A role for surgery in the treatment of relapsed Hodgkin lymphoma.

@article{Fahy2019ARF,
  title={A role for surgery in the treatment of relapsed Hodgkin lymphoma.},
  author={A S Fahy and I. L. Kong and Sheila S Weitzman and David Dix and Sylvain Baruchel and J. Ted Gerstle},
  journal={Pediatric blood & cancer},
  year={2019},
  volume={66 1},
  pages={
          e27402
        }
}
Treatment of Hodgkin lymphoma (HL) has advanced over time, rendering a fatal disease now largely curable. Multiagent chemotherapy regimens, hematopoietic stem cell transplantation, and radiotherapy are the mainstays of care. Surgical intervention is rarely indicated other than for biopsy at diagnosis. However, for patients with recurrent relapsed HL isolated to one anatomical location, refractory to all other therapy, there may be a beneficial role for surgical excision. Herein, we report the… CONTINUE READING